North Tide Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$47.8M |
| 2 |
Community Health Systems
CYH
|
+$42.9M |
| 3 |
Quest Diagnostics
DGX
|
+$41.9M |
| 4 |
Elevance Health
ELV
|
+$38.6M |
| 5 |
Viatris
VTRS
|
+$31.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBMD
WebMD Health Corp.
WBMD
|
+$14.7M |
| 2 |
MAKO
MAKO SURGICAL CORP COM
MAKO
|
+$9.64M |
| 3 |
Boston Scientific
BSX
|
+$4.33M |
| 4 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
+$4.26M |
| 5 |
WCRX
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
|
+$4.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.41% |
| 2 | Consumer Discretionary | 2.78% |
| 3 | Financials | 1.69% |
Similar funds
North Tide Capital's Q3 2013 Portfolio in Review
As of Q3 2013, North Tide Capital held 31 positions worth $953M, up 69% from $564M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
North Tide Capital deployed $351M of net new capital in Q3 2013, opening 8 new positions and adding to 12 existing holdings. Its largest new stake was Community Health Systems: 1,210,000 shares worth $41.5M.
By sector, the portfolio is most concentrated in Healthcare at 65% of assets, up from 51% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Boston Scientific, an estimated $4.33M trimmed.
- North Tide Capital's largest Q3 2013 buy was Community Health Systems: 1,210,000 shares worth $41.5M.
- North Tide Capital added most to Teva Pharmaceuticals in Q3 2013, an estimated $47.8M increase.
- North Tide Capital's biggest Q3 2013 reduction was Boston Scientific, cutting an estimated $4.33M.
- North Tide Capital fully exited WebMD Health Corp. in Q3 2013, selling an estimated $14.7M.
- North Tide Capital's ten largest holdings make up 69% of its $953M portfolio in Q3 2013.
- North Tide Capital opened 8 new positions and closed 4 in Q3 2013.
- North Tide Capital's portfolio value rose 69% quarter-over-quarter to $953M.
Based on North Tide Capital's 13F filing for Q3 2013, filed 14 Nov 2013.